Keudell/Morrison Wealth Management’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,306	Closed	-$273K	–	235
2024 Q3	$273K	Buy	4,306 +241	+6%	+$15.3K	0.07%	172
2024 Q2	$215K	Buy	4,065 +1,045	+35%	+$55.4K	0.06%	190
2024 Q1	$248K	Buy	+3,020	New	+$248K	0.08%	178